Federal Bio Services
Healthcare · Lobbying Client
C
Influence Score
46/100
Moderate Influence
$987K
Total Lobby Spend
6
Policy Issues
1
Lobbyists
0
Revolving Door
Federal Bio Services reported $987,000 in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Health Issues, Medical/Disease Research, Medicare/Medicaid. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of State
Federal Trade Commission
Federal Aviation Administration
US House of Representatives
White House
Dept of Health & Human Services
US Senate
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Brownstein Hyatt LLP | MEDGOVHCR+2 | 1 | $57K |
| 2020 Apr-Jun | BGR Group LLP | AVIMMMGOV+1 | 1 | $55K |
| 2020 Jul-Sep | Covington & Burling LLP | MEDAVIGOV+1 | 1 | $62K |
| 2020 Oct-Dec | Squire Patton Boggs LLP | MMMHCRAVI+2 | 1 | $39K |
| 2021 Jan-Mar | K&L Gates LLP | AVI | 1 | $50K |
| 2021 Apr-Jun | Akin Gump LLP | GOVHCRMMM | 1 | $52K |
| 2021 Jul-Sep | Squire Patton Boggs LLP | MED | 1 | $50K |
| 2021 Oct-Dec | Squire Patton Boggs LLP | MEDGOVAPP | 1 | $67K |